|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0012655,
umls-concept:C0026882,
umls-concept:C0027651,
umls-concept:C0031437,
umls-concept:C0332281,
umls-concept:C0580822,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C1835898
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-5-1
|
|
pubmed:abstractText |
To determine the effect of the breast cancer susceptibility mutation PALB2 1592delT on tumor phenotype and patient survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/BLID protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/BRCA2 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/BRCA2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PALB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3214-22
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19383810-Adult,
pubmed-meshheading:19383810-Aged,
pubmed-meshheading:19383810-Aged, 80 and over,
pubmed-meshheading:19383810-Apoptosis Regulatory Proteins,
pubmed-meshheading:19383810-BRCA1 Protein,
pubmed-meshheading:19383810-BRCA2 Protein,
pubmed-meshheading:19383810-Breast Neoplasms,
pubmed-meshheading:19383810-Carcinoma, Ductal, Breast,
pubmed-meshheading:19383810-Carcinoma, Lobular,
pubmed-meshheading:19383810-Female,
pubmed-meshheading:19383810-Genetic Predisposition to Disease,
pubmed-meshheading:19383810-Humans,
pubmed-meshheading:19383810-Middle Aged,
pubmed-meshheading:19383810-Mutation,
pubmed-meshheading:19383810-Nuclear Proteins,
pubmed-meshheading:19383810-Phenotype,
pubmed-meshheading:19383810-Receptor, erbB-2,
pubmed-meshheading:19383810-Receptors, Estrogen,
pubmed-meshheading:19383810-Receptors, Progesterone,
pubmed-meshheading:19383810-Tumor Suppressor Proteins,
pubmed-meshheading:19383810-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
